ARBUTUS BIOPHARMA CORPORATION |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 3,200 USD | -0,62% |
|
-2,74% | -2,14% |
| 03/12 | Arbutus Biopharma Corporation - Special Call | |
| 21/11 | ARBUTUS BIOPHARMA CORPORATION : Chardan Research mantiene la raccomandazione Buy | ZM |
Principali concorrenti
Aggiungi a un elenco 0 selezionato | Variaz. | Variaz. 5g. | Variazione 1 mese | Variazione 3 mesi | Variaz. 1 gen. | Variaz. 1 anno | Variaz. 3 anni | Variaz. 5 anni | Variaz. 10 anni | Capi. ($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0,62% | -2,74% | -0,31% | -22,89% | -2,14% | +35,59% | +6,31% | +4,23% | -86,78% | 606 Mln | ||
| +0,38% | +2,17% | +4,75% | +2,43% | +3,81% | +49,16% | -15,37% | +51,39% | +488,57% | 43,8 Mrd | ||
| -0,15% | -2,91% | +3,05% | -16,62% | +0,43% | -8,37% | -17,86% | +22,20% | +231,25% | 35,82 Mrd | ||
| -1,10% | -2,76% | -1,77% | +0,32% | -4,00% | +7,39% | +17,70% | +16,86% | +493,63% | 26,23 Mrd | ||
| -2,15% | -9,22% | -3,18% | -33,46% | -5,53% | -23,68% | -22,93% | +12,70% | +243,46% | 16,36 Mrd | ||
| -2,04% | -1,65% | -0,34% | -2,58% | +1,73% | +64,77% | +75,03% | +285,41% | +154,40% | 16,02 Mrd | ||
| +0,89% | -19,38% | -13,90% | -37,04% | -18,09% | -65,84% | -80,43% | +65,18% | - | 13,11 Mrd | ||
| -0,35% | +3,44% | +6,22% | +6,44% | +5,28% | +7,84% | -20,14% | +37,49% | +225,94% | 12,05 Mrd | ||
| +0,16% | -3,85% | +0,66% | -5,35% | +1,54% | +14,09% | +103,36% | +270,92% | - | 10,46 Mrd | ||
| +0,22% | +2,95% | +3,79% | +6,98% | +3,30% | -1,13% | -10,38% | +24,78% | +80,61% | 10,22 Mrd | ||
| -1,39% | -12,15% | -10,24% | -17,33% | -11,43% | -22,89% | -51,44% | +2,33% | +139,70% | 8,36 Mrd | ||
| +0,98% | -3,57% | -6,93% | -20,11% | -7,89% | +49,61% | +68,58% | - | - | 7,45 Mrd | ||
| +5,87% | +25,87% | +23,75% | +27,97% | +26,18% | +35,78% | +51,77% | +35,70% | - | 6,99 Mrd | ||
| -.--% | -.--% | - | - | - | - | - | - | - | 6,07 Mrd | ||
| +0,85% | +3,68% | -9,43% | -9,04% | -2,49% | -1,99% | -56,69% | -1,37% | - | 5,55 Mrd | ||
| +1,15% | -6,32% | +6,42% | -28,76% | +4,12% | - | - | - | - | 5,53 Mrd | ||
| -1,84% | +8,66% | +5,50% | +21,45% | +6,05% | +135,14% | +263,00% | +1.640,00% | - | 5,53 Mrd | ||
| +0,32% | +1,41% | -18,83% | -22,25% | -8,90% | +1,76% | -58,15% | -32,21% | +393,98% | 5,47 Mrd | ||
| -2,63% | -6,07% | -11,69% | -20,79% | -10,10% | -38,35% | +3,66% | -47,73% | -54,69% | 4,96 Mrd | ||
| -0,94% | +4,95% | -1,67% | +4,24% | +2,47% | +5,63% | +17,88% | +53,17% | -57,90% | 4,77 Mrd | ||
| Media | -0,12% | -0,95% | -1,27% | -8,76% | -0,82% | +13,58% | +15,22% | +143,59% | +187,68% | 12,27 Mrd | |
| Media ponderata per Capi. | -0,21% | -1,92% | +0,10% | -7,81% | -0,53% | +13,25% | +4,40% | +96,50% | +299,76% |
- Borsa valori
- Azioni
- Azione ABUS
- Settore Arbutus Biopharma Corporation
MarketScreener is also available in this country: United States.
Switch edition
Rimanere sul sito del Paese attuale